To Check for Scarring without a Procedure
APRI comes from a blood sample. A low score suggests significant scarring is unlikely. That can reduce the need for more invasive testing.
AI Summary The APRI score is a blood test calculation that uses AST and platelet count to estimate liver scarring (fibrosis) without a procedure. A score below 0.5 makes cirrhosis unlikely, 0.5 to 1.5 is indeterminate, and above 1.5 suggests advanced fibrosis. APRI cannot confirm a diagnosis, measure liver fat, or name the cause, and other conditions can change the result. Middle or high scores usually lead to elastography, and sometimes a liver biopsy.
Source: www.liverdirectory.com
Medically Reviewed.
The APRI score (AST to Platelet Ratio Index) is a calculation based on two routine blood results: AST, a liver enzyme, and your platelet count. Doctors use it to estimate whether you may have significant liver scarring (fibrosis) or cirrhosis.
It needs only a blood draw, so no procedure is involved. APRI is an estimate, not a diagnosis. Your care team reads it with your other results and may suggest more testing.
Ask Aimy
Aimy answers from LiverDirectory’s reviewed health information — helping patients make sense of liver-health terms, prepare for specialist visits, and explore what to look up next.
APRI Test Basics
The APRI score stands for AST to Platelet Ratio Index. It is a blood-based test that estimates how much fibrosis, or scar tissue, has built up in your liver. You may also see it called the APRI test.
APRI uses two values from routine blood work. AST (aspartate aminotransferase) is an enzyme that leaks into your blood when liver cells are damaged. Platelets are blood cells that help your blood clot. Your lab or doctor compares the two in a ratio. A higher AST or a lower platelet count pushes the score up.
APRI measures scarring only. It does not measure fat in the liver (steatosis) or inflammation directly. It uses AST and platelets as indirect signs of how severe the damage may be.
APRI belongs to a group of fibrosis scores. The closest relatives are the FIB-3 and FIB-4 scores and the ELF score.
Liver Fibrosis Screening
APRI answers one question: how likely is it that your liver has advanced scarring? It is not an everyday liver test.
APRI comes from a blood sample. A low score suggests significant scarring is unlikely. That can reduce the need for more invasive testing.
Doctors use fibrosis scores for people with long-term liver conditions, such as hepatitis B, hepatitis C, [fatty liver disease](/liver-diseases/metabolic-liver-diseases/fatty-liver-disease), and alcohol-related liver disease.
The score cutoffs help your care team decide whether you need more testing. A middle or high score usually leads to a second test, such as an elastography scan.
Fibrosis scores can also help track scarring and response to treatment in chronic liver disease. Your care team decides how often to check.
APRI Score Ranges Explained
Most labs and clinics use two cutoffs, 0.5 and 1.5. Your report may show slightly different wording, so ask your care team how they read it.
APRI helps sort people into lower and higher risk. It does not stage your fibrosis or tell you the cause of your liver disease.
Fibrosis Blood Test Comparison
All three estimate scarring from blood tests. They use different inputs and different cutoffs, so do not compare numbers across tests.
| Score | What It Uses | Low Result | Middle Result | High Result |
|---|---|---|---|---|
| APRI | AST and platelet count | Below 0.5 | 0.5 to 1.5 | Above 1.5 |
| FIB-4 | Age, AST, ALT, and platelet count | Below 1.45 | 1.45 to 3.25 | Above 3.25 |
| ELF | Three fibrosis markers: hyaluronic acid, PIIINP, and TIMP-1 | Below 7.7 | 7.7 to 9.8 | Above 9.8 |
Some guidelines use FIB-4 cutoffs of about 1.3 and 2.6 instead. Ask your care team which cutoffs they use.
APRI Test Accuracy and Limits
APRI is useful, but it has clear limits. Knowing them helps you read your result calmly.
A high score raises the chance of advanced fibrosis or cirrhosis. It does not prove it. Blood-based tests are better at ruling advanced fibrosis out than at ruling it in, so a positive result is usually followed by another test.
APRI looks at scarring only. It does not show how much fat is in your liver or how inflamed it is, and it does not name the cause of your liver disease.
AST also comes from muscle and the heart, and low platelets have causes outside the liver. Acute hepatitis, hemolysis, Gilbert's syndrome, low platelets from HIV, spleen removal, high bilirubin, and body-wide inflammation can also give false positive or false negative results.
A result between 0.5 and 1.5 neither rules in nor rules out advanced liver disease. It needs a follow-up test to sort out.
Follow-Up Testing Options
Significant scarring is unlikely, and you may not need more invasive testing right away. Your care team may still suggest monitoring, depending on your risk factors, such as the cause of your liver disease.
A staged approach is recommended. A simple blood score comes first. A confirmatory test follows, such as [elastography](/liver-tests/imaging-non-invasive-testing/elastography-fibrosis-testing), which measures how stiff the liver is. A doctor who treats liver disease can guide this step.
Your doctor may discuss a [liver biopsy](/liver-tests/invasive-testing/liver-biopsy). Biopsy is usually reserved for cases where noninvasive results are ambiguous or advanced disease needs confirming.
A balanced, liver-friendly diet supports your liver, helps manage weight and blood sugar, and lowers the risk of other health problems during long-term follow-up.
Explore Liver DietThe Amsety Bar is a liver-friendly snack or meal replacement that can make it easier to eat well on busy days.
Shop Amsety Bars
Common Questions
A score below 0.5 is considered low, meaning cirrhosis is unlikely. Most labs and clinics use two cutoffs, 0.5 and 1.5. Scores from 0.5 to 1.5 are indeterminate, which means the result does not clearly rule advanced liver disease in or out. Scores above 1.5 suggest a higher likelihood of cirrhosis or advanced fibrosis. A low score is the most useful result, because APRI is better at ruling out cirrhosis than at confirming it. Your care team reads the number alongside your health history and your other test results.
APRI compares your AST level with your platelet count, both from routine blood tests. AST is a liver enzyme that leaks into your blood when liver cells are damaged. Platelets are blood cells that help your blood clot. A higher AST or a lower platelet count pushes the score up. Your lab or doctor does the calculation, so you do not need to work it out yourself. You only need a blood draw, and no procedure is involved.
No. A high score means cirrhosis or advanced fibrosis is more likely, but it does not confirm a diagnosis. Blood-based scores are less reliable at ruling fibrosis in than at ruling it out. Other conditions can also change the result, such as acute hepatitis, low platelets from causes outside the liver, or body-wide inflammation. A high score means your liver needs a closer look. Expect a follow-up test, such as elastography, which measures how stiff the liver is. A doctor who treats liver disease can guide the next steps.
Neither is clearly better. Current guidelines recommend both over no testing to detect significant and advanced fibrosis. The two scores use different inputs and different cutoffs. APRI uses AST and platelet count. FIB-4 also uses age and ALT, and guidelines often name it as the first screening step for fatty liver disease. Because the cutoffs differ, do not compare the numbers across tests. Your doctor picks the score that fits your situation.
The score reflects liver damage, so it may change as your liver condition changes. It is not a number you can adjust directly. Treating the cause of your liver disease is the key step, and your care team can advise on it. A balanced, liver-friendly diet also supports long-term liver care. Do not try to change the number itself. Ask your care team how often to repeat the test and what a change in your score would mean for you.
Medical disclaimer: LiverDirectory provides educational information and a directory of providers. It does not provide medical advice, diagnosis, or treatment. Always consult a licensed physician regarding any medical condition.